CSF levels and ratio of NfH phosphoforms for clinically progressive versus stable patients at baseline. Values are median (interquartile range)
| MS (all patients) | SP/PP | RR | ||||
|---|---|---|---|---|---|---|
| Stable | Progressive | Stable | Progressive | Stable | Progressive | |
| See table 2 for abbreviations. | ||||||
| Number | 19 | 15 | 16 | 7 | 3 | 8 |
| NfHSMI35 (pg/ml) | 38 (17–155) | 107 (49–163) | 42 (24–173) | 104 (78–173) | 5 (0–53) | 115 (43–165) |
| NfHSMI34 (pg/ml) | 11 (5–13) | 8 (5–14) | 11 (7.5–13.0) | 9 (5–16) | 2 (0–5) | 7.5 (6–11) |
| Ratio | 3.2 (0.6–5.8) | 1.0 (0.4–3.5) | 3.2 (0.6–6.0) | 1.1 (0.5–1.7) | 2.5 (0.9–4.0) | 0.9 (0.4–3.5) |